BlackRock Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $12.3M | Buy |
161,568
+27,059
| +20% | +$2.06M | 0.01% | 980 |
|
|
2016
Q3 | $11.2M | Buy |
134,509
+458
| +0.3% | +$38.2K | 0.01% | 930 |
|
|
2016
Q2 | $11.1M | Buy |
134,051
+4,628
| +4% | +$382K | 0.01% | 892 |
|
|
2016
Q1 | $9.83M | Sell |
129,423
-29,397
| -19% | -$2.23M | 0.01% | 936 |
|
|
2015
Q4 | $12.8M | Sell |
158,820
-39,509
| -20% | -$3.18M | 0.02% | 803 |
|
|
2015
Q3 | $12.6M | Sell |
198,329
-2,222
| -1% | -$141K | 0.02% | 786 |
|
|
2015
Q2 | $14.1M | Buy |
200,551
+10,811
| +6% | +$760K | 0.02% | 764 |
|
|
2015
Q1 | $15M | Buy |
189,740
+5,763
| +3% | +$457K | 0.02% | 712 |
|
|
2014
Q4 | $11.7M | Buy |
183,977
+2,814
| +2% | +$179K | 0.02% | 839 |
|
|
2014
Q3 | $10.8M | Sell |
181,163
-1,609
| -0.9% | -$96.1K | 0.02% | 874 |
|
|
2014
Q2 | $9.78M | Buy |
182,772
+47,733
| +35% | +$2.55M | 0.01% | 980 |
|
|
2014
Q1 | $8.15M | Sell |
135,039
-2,713
| -2% | -$164K | 0.01% | 1055 |
|
|
2013
Q4 | $7.31M | Sell |
137,752
-3,493
| -2% | -$185K | 0.01% | 1093 |
|
|
2013
Q3 | $6.53M | Buy |
141,245
+12,785
| +10% | +$591K | 0.01% | 1109 |
|
|
2013
Q2 | $5.27M | Buy |
+128,460
| New | +$5.27M | 0.01% | 1177 |
|